Effects of Vitamin B3 in Patients with Ataxia Telangiectasia
Sponsor: Radboud University
Collaborators: A-T childrens project Twan foundation
Purpose
Investigates the effects of nicotinamide ribosdie (vitamin B3) on the disease course of patients with ataxia telangiectasia.
Study Design
Open label proof of concept, single group
Dose
25mg/kg/day
Length of Intervention
6 months, 4 months on NR
Intrinsic Capacity
Locomotion
Status
Enrolling by invitation
Condition or Disease
Ataxia Telangiectasia
ATM Gene Mutation
Timeline estimations sourced on clinicaltrials.gov. All timing subject to change.